Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study

OBJECTIVE: The aim of this study is to determine the safety and the efficacy of amifampridine phosphate in muscle-specific kinase antibody-positive myasthenia gravis, in a 1:1 randomized, double-blind, placebo-controlled, switchback, double crossover study. METHODS: Eligible patients had muscle-spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonanno, Silvia, Pasanisi, Maria Barbara, Frangiamore, Rita, Maggi, Lorenzo, Antozzi, Carlo, Andreetta, Francesca, Campanella, Angela, Brenna, Greta, Cottini, Lorenzo, Mantegazza, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299310/
https://www.ncbi.nlm.nih.gov/pubmed/30574306
http://dx.doi.org/10.1177/2050312118819013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299310/
https://www.ncbi.nlm.nih.gov/pubmed/30574306
http://dx.doi.org/10.1177/2050312118819013

Ejemplares similares